Diabetes

Top Story

Diabetes, poor glycemic control linked to death, CV events after CABG

July 28, 2015

In patients with type 1 diabetes, poor glycemic control was associated with increased long-term risk for death and major adverse CV events after CABG in a population-based cohort study.

Researchers investigated whether preoperative HbA1c levels predicted death or CV events after CABG for patients with type 1 diabetes.

James Floyd In the Journals

CV risk similar for second-line diabetes drugs plus metformin

July 27, 2015
Adults with type 2 diabetes using metformin combined with insulin have a similar cardiovascular risk when compared with adults using metformin combined with…
Kim Allan Williams, MD

ACC announces new industry sponsor for Diabetes Collaborative Registry

July 25, 2015
The American College of Cardiology announced that Boehringer Ingelheim has become the latest industry sponsor of the Diabetes Collaborative Registry.The registry was…
In the Journals

Cardiometabolic multimorbidity reduces life expectancy

July 9, 2015
The risk for mortality is similar among patients with diabetes, stroke or MI, but a combination of these conditions was associated with a substantial decrease in life…
CME
Cardiology Case Consults

The Patient With Idiopathic Pulmonary Fibrosis

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with idiopathic pulmonary fibrosis.
More »
Meeting News Coverage Video
VIDEO: Best CVD treatment approach for patients with diabetes still unclear

VIDEO: Best CVD treatment approach for patients with diabetes still unclear

May 31, 2015
SAN DIEGO — Spencer King, III, MD, MACC, of the cardiology department at Emory Saint Joseph’s Hospital and…
More »
Thomas M. Maddox, MD, MSc, FACC, FAHA In the Journals

Diabetes, poor glycemic control linked to death, CV events after CABG

July 28, 2015
In patients with type 1 diabetes, poor glycemic control was associated with increased long-term risk for death and major adverse CV events after CABG…
James Floyd In the Journals

CV risk similar for second-line diabetes drugs plus metformin

July 27, 2015
Adults with type 2 diabetes using metformin combined with insulin have a similar cardiovascular risk when compared with adults using metformin…
Kim Allan Williams, MD

ACC announces new industry sponsor for Diabetes Collaborative Registry

July 25, 2015
The American College of Cardiology announced that Boehringer Ingelheim has become the latest industry sponsor of the Diabetes Collaborative…
In the Journals

Cardiometabolic multimorbidity reduces life expectancy

July 9, 2015
The risk for mortality is similar among patients with diabetes, stroke or MI, but a combination of these conditions was associated with a substantial…
Meeting News Coverage

Genetic variant reduces coronary events, increases diabetes risk in familial hypercholesterolemia

June 30, 2015
CHICAGO — A PCSK9 loss-of-function genetic variant was associated with a cardioprotective effect, but increased prevalence of diabetes and…
In the Journals

Preventable risk factors related to half of CV deaths in US adults

June 30, 2015
Preventable risk factors accounted for half of CV deaths in U.S. adults aged 45 to 79 years from 2009 to 2010, according to an analysis published in…
Cardiology Case Consults

The Patient With Idiopathic Pulmonary Fibrosis

July 15, 2015 Expires: 7/15/2016
This CME activity will focus on the diagnosis and management of patients with idiopathic pulmonary fibrosis…
VIDEO: Expert discusses relationship between statin therapy, diabetes Meeting News CoverageVideo

VIDEO: Expert discusses relationship between statin therapy, diabetes

June 12, 2015
CHICAGO — Health care professionals should be aware of the link between statin use and increased risk for type 2 diabetes, especially among…
Rury Holman Meeting News CoveragePerspective

No additional threat of heart failure with Januvia in high-risk adults with type 2 diabetes

June 8, 2015
BOSTON – The DPP-IV inhibitor Januvia does not increase cardiovascular risk or benefit in adults with type 2 diabetes at high risk for acute…
Matthew Riddle Meeting News Coverage

Lyxumia trial shows neutral CV risk in adults with type 2 diabetes, high risk for CVD

June 8, 2015
BOSTON — The GLP-1 receptor agonist Lyxumia lowers HbA1c without any cardiovascular risk or benefit in adults with type 2 diabetes at high risk…
More Headlines »
morganatic-roan
morganatic-roan